StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note issued to investors on Monday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Trading Down 7.3 % Brooklyn ImmunoTherapeutics stock opened at $1.01 on Monday. The firm has a market cap of $59.41 million, a […]
StockNews.com started coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of NYSE:BTX opened at $1.15 on Friday. Brooklyn ImmunoTherapeutics has a one year low of $0.17 and a one year high of $10.10. […]
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research report released on Thursday morning. The brokerage issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Down 8.8 % Shares of BTX opened at $1.76 on Thursday. The firm has a 50-day moving average price of $2.24 and a […]
StockNews.com assumed coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report released on Tuesday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Stock Up 5.7 % Shares of Brooklyn ImmunoTherapeutics stock opened at $2.23 on Tuesday. The stock’s 50-day simple moving average is $2.39 and its 200-day […]
StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a research note released on Saturday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance Shares of BTX opened at $2.20 on Friday. Brooklyn ImmunoTherapeutics has a 1-year low of $0.17 and a 1-year high of $10.10. […]